Eli Lilly Other Equity decreased by 29.0% to $22.00M in Q4 2025 compared to the prior quarter.
Significant changes may indicate share buyback programs or unique accounting adjustments that warrant further investigation in the footnotes.
A catch-all category for equity components that do not fit into standard classifications like retained earnings or commo...
Varies by company; often contains treasury stock which is common for companies with active share repurchase programs.
other_equity| Q4 '24 | Q4 '25 | |
|---|---|---|
| Value | $31.00M | $22.00M |
| QoQ Change | — | -29.0% |
| YoY Change | — | -29.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.